Effects of opioid subtypes on detrusor overactivity in rats with cerebral infarction

Authors


Osamu Yokoyama md, phd, Department of Urology, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan. Email: oyoko@fmsrsa.fukui-med.ac.jp

Abstract

Aim:  In order to determine the influence of different opioid receptor subtypes on detrusor overactivity after left middle cerebral artery (MCA) occlusion, cystometric recordings were obtained in conscious rats.

Methods:  Female Sprague-Dawley rats were used in this study. Control cystometrography was followed by left MCA occlusion. The sham-operated (SO) rats underwent the same procedures except for MCA occlusion. [D-Ala2, Phe4, Gly5]-enkephalin (DAGO; μ-opioid agonist), [D-Pen2,5]-enkephalin (DPDPE; δ1-opioid agonist), deltorpin II (δ2-opioid agonist), and U-50488 (κ-opioid agonist) were administered intracerebroventricularly at graded doses. The bladder capacity, residual volume, micturition threshold pressure, and bladder contraction pressure were determined. Finally, the volume of the infarction was measured.

Results:  The intracerebroventricular administration of DAGO and DPDPE significantly increased the bladder capacity in the cerebrally infarcted (CI) and SO rats, but differences in the changes in bladder capacity between the CI and SO rats were not significant. Deltorpin II did not produce any changes in the bladder capacity in the CI or SO rats at any dose examined. However, the intracerebroventricular administration of U-50488 significantly increased the bladder capacity in the CI rats but not in the SO rats. None of the drugs affected the residual volume, micturition threshold pressure or bladder contraction pressure at any dosage examined. The mean infarcted volumes were not significantly different from those in the vehicle-treated rats.

Conclusion:  These results suggest that the opioid receptor subtypes, μ and δ1 in the brain, are related to the micturition reflex. Furthermore, the κ opioid agonist might be useful for the suppression of detrusor overactivity caused by cerebral infarction.

Ancillary